secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0000313143-26-000023
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics director Charles Dockendorff will not stand for re-election at 2026 annual meeting
--------------------------------------------------------------------------------

- Charles J. Dockendorff, Board member since 2014, will not stand for re-election at the 2026 Annual Meeting.
- He serves on the Audit Committee and the Governance and Compliance Committee.
- His decision is not the result of any disagreement with the company.
- He will continue as a director and in his committee roles until the 2026 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000023/0000313143-26-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000023/hae-20260427.htm
  HTML page:      https://secwatch.observer/filing/0000313143-26-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer